{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T12:03:23Z","timestamp":1792843403435,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T00:00:00Z","timestamp":1675123200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T00:00:00Z","timestamp":1675123200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100010909","name":"Young Scientists Fund","doi-asserted-by":"publisher","award":["81800445"],"award-info":[{"award-number":["81800445"]}],"id":[{"id":"10.13039\/501100010909","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sleep Breath"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s11325-023-02781-9","type":"journal-article","created":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T07:13:17Z","timestamp":1675149197000},"page":"1769-1777","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Sacubitril\/valsartan mitigated intermittent hypoxia related intestinal microbiota alteration and aortic injury"],"prefix":"10.1007","volume":"27","author":[{"given":"Jinfeng","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LiJuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5423-9912","authenticated-orcid":false,"given":"Dasheng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,31]]},"reference":[{"key":"2781_CR1","unstructured":"Benjafield A et al (2018) in B67. Risk and prevalence of sleep disordered breathing A3962-A3962 (American Thoracic Society)"},{"key":"2781_CR2","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s10741-008-9101-2","volume":"14","author":"K Devulapally","year":"2009","unstructured":"Devulapally K, Pongonis R Jr, Khayat R (2009) OSA: the new cardiovascular disease: part II: overview of cardiovascular diseases associated with obstructive sleep apnea. Heart Fail Rev 14:155\u2013164. https:\/\/doi.org\/10.1007\/s10741-008-9101-2","journal-title":"Heart Fail Rev"},{"key":"2781_CR3","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1164\/rccm.200503-340OC","volume":"172","author":"LF Drager","year":"2005","unstructured":"Drager LF et al (2005) Early signs of atherosclerosis in obstructive sleep apnea. Am J Respir Crit Care Med 172:613\u2013618. https:\/\/doi.org\/10.1164\/rccm.200503-340OC","journal-title":"Am J Respir Crit Care Med"},{"key":"2781_CR4","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1378\/chest.10-2223","volume":"140","author":"LF Drager","year":"2011","unstructured":"Drager LF, Polotsky VY, Lorenzi-Filho G (2011) Obstructive sleep apnea: an emerging risk factor for atherosclerosis. Chest 140:534\u2013542. https:\/\/doi.org\/10.1378\/chest.10-2223","journal-title":"Chest"},{"key":"2781_CR5","doi-asserted-by":"publisher","first-page":"8215082","DOI":"10.1155\/2016\/8215082","volume":"2016","author":"L Ma","year":"2016","unstructured":"Ma L, Zhang J, Liu Y (2016) Roles and mechanisms of obstructive sleep apnea-hypopnea syndrome and chronic intermittent hypoxia in atherosclerosis: evidence and prospective. Oxid Med Cell Longev 2016:8215082. https:\/\/doi.org\/10.1155\/2016\/8215082","journal-title":"Oxid Med Cell Longev"},{"key":"2781_CR6","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1161\/circresaha.117.309715","volume":"120","author":"WH Tang","year":"2017","unstructured":"Tang WH, Kitai T, Hazen SL (2017) Gut microbiota in cardiovascular health and disease. Circ Res 120:1183\u20131196. https:\/\/doi.org\/10.1161\/circresaha.117.309715","journal-title":"Circ Res"},{"key":"2781_CR7","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.chest.2018.03.001","volume":"154","author":"N Farr\u00e9","year":"2018","unstructured":"Farr\u00e9 N, Farr\u00e9 R, Gozal D (2018) Sleep apnea morbidity: a consequence of microbial-immune cross-talk? Chest 154:754\u2013759. https:\/\/doi.org\/10.1016\/j.chest.2018.03.001","journal-title":"Chest"},{"key":"2781_CR8","doi-asserted-by":"publisher","first-page":"6509","DOI":"10.1038\/s41598-019-42994-1","volume":"9","author":"H Zhang","year":"2019","unstructured":"Zhang H et al (2019) Neprilysin inhibitor-angiotensin II receptor blocker combination therapy (sacubitril\/valsartan) suppresses atherosclerotic plaque formation and inhibits inflammation in apolipoprotein E-deficient mice. Sci Rep 9:6509. https:\/\/doi.org\/10.1038\/s41598-019-42994-1","journal-title":"Sci Rep"},{"key":"2781_CR9","doi-asserted-by":"publisher","first-page":"118500","DOI":"10.1016\/j.lfs.2020.118500","volume":"262","author":"D Lu","year":"2020","unstructured":"Lu D, Wang J, Zhang H, Shan Q, Zhou B (2020) Renal denervation improves chronic intermittent hypoxia induced hypertension and cardiac fibrosis and balances gut microbiota. Life Sci 262:118500","journal-title":"Life Sci"},{"key":"2781_CR10","doi-asserted-by":"publisher","first-page":"123963","DOI":"10.1155\/2014\/123963","volume":"2014","author":"Y Wang","year":"2014","unstructured":"Wang Y et al (2014) Sulforaphane attenuation of type 2 diabetes-induced aortic damage was associated with the upregulation of Nrf2 expression and function. Oxidative Med Cell longev 2014:123963. https:\/\/doi.org\/10.1155\/2014\/123963","journal-title":"Oxidative Med Cell longev"},{"key":"2781_CR11","doi-asserted-by":"publisher","first-page":"165884","DOI":"10.1016\/j.bbadis.2020.165884","volume":"1866","author":"F Zhang","year":"2020","unstructured":"Zhang F et al (2020) 5-Fluorouracil induced dysregulation of the microbiome-gut-brain axis manifesting as depressive like behaviors in rats. Biochim Biophys Acta Mol Basis Dis 1866:165884. https:\/\/doi.org\/10.1016\/j.bbadis.2020.165884","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"2781_CR12","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1038\/nbt.2676","volume":"31","author":"MG Langille","year":"2013","unstructured":"Langille MG et al (2013) Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat Biotechnol 31:814\u2013821. https:\/\/doi.org\/10.1038\/nbt.2676","journal-title":"Nat Biotechnol"},{"key":"2781_CR13","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1038\/nature08530","volume":"461","author":"KM Maslowski","year":"2009","unstructured":"Maslowski KM et al (2009) Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 461:1282\u20131286. https:\/\/doi.org\/10.1038\/nature08530","journal-title":"Nature"},{"key":"2781_CR14","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.ebiom.2018.11.010","volume":"38","author":"EF Lucking","year":"2018","unstructured":"Lucking EF et al (2018) Chronic intermittent hypoxia disrupts cardiorespiratory homeostasis and gut microbiota composition in adult male guinea-pigs. EBioMedicine 38:191\u2013205. https:\/\/doi.org\/10.1016\/j.ebiom.2018.11.010","journal-title":"EBioMedicine"},{"key":"2781_CR15","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1161\/01.hyp.0000153794.52852.04","volume":"45","author":"KJ Allahdadi","year":"2005","unstructured":"Allahdadi KJ, Walker BR, Kanagy NL (2005) Augmented endothelin vasoconstriction in intermittent hypoxia-induced hypertension. Hypertension (Dallas, Tex.\u202f: 1979) 45:705\u2013709. https:\/\/doi.org\/10.1161\/01.hyp.0000153794.52852.04","journal-title":"Hypertension (Dallas, Tex. : 1979)"},{"key":"2781_CR16","doi-asserted-by":"publisher","first-page":"635","DOI":"10.3389\/fneur.2018.00635","volume":"9","author":"A Gabryelska","year":"2018","unstructured":"Gabryelska A, \u0141ukasik ZM, Makowska JS, Bia\u0142asiewicz P (2018) Obstructive sleep apnea: from intermittent hypoxia to cardiovascular complications via blood platelets. Front Neurol 9:635. https:\/\/doi.org\/10.3389\/fneur.2018.00635","journal-title":"Front Neurol"},{"key":"2781_CR17","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s10741-018-9757-1","volume":"24","author":"AJ Sauer","year":"2019","unstructured":"Sauer AJ et al (2019) Practical guidance on the use of sacubitril\/valsartan for heart failure. Heart Fail Rev 24:167\u2013176. https:\/\/doi.org\/10.1007\/s10741-018-9757-1","journal-title":"Heart Fail Rev"},{"key":"2781_CR18","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1177\/1753944718784536","volume":"12","author":"S Yandrapalli","year":"2018","unstructured":"Yandrapalli S, Khan MH, Rochlani Y, Aronow WS (2018) Sacubitril\/valsartan in cardiovascular disease: evidence to date and place in therapy. Ther Adv Cardiovasc Dis 12:217\u2013231. https:\/\/doi.org\/10.1177\/1753944718784536","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"2781_CR19","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1183\/09031936.00184314","volume":"45","author":"I Moreno-Indias","year":"2015","unstructured":"Moreno-Indias I et al (2015) Intermittent hypoxia alters gut microbiota diversity in a mouse model of sleep apnoea. Eur Respir J 45:1055\u20131065. https:\/\/doi.org\/10.1183\/09031936.00184314","journal-title":"Eur Respir J"},{"key":"2781_CR20","doi-asserted-by":"publisher","unstructured":"Tripathi A et al (2019) Intermittent hypoxia and hypercapnia reproducibly change the gut microbiome and metabolome across rodent model systems. mSystems 4.\u00a0https:\/\/doi.org\/10.1128\/mSystems.00058-19","DOI":"10.1128\/mSystems.00058-19"},{"key":"2781_CR21","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1161\/hypertensionaha.115.06672","volume":"67","author":"DJ Durgan","year":"2016","unstructured":"Durgan DJ et al (2016) Role of the gut microbiome in obstructive sleep apnea-induced hypertension. Hypertension 67:469\u2013474. https:\/\/doi.org\/10.1161\/hypertensionaha.115.06672","journal-title":"Hypertension"},{"key":"2781_CR22","doi-asserted-by":"publisher","unstructured":"Tripathi A et al (2018) Intermittent hypoxia and hypercapnia, a hallmark of obstructive sleep apnea, alters the gut microbiome and metabolome. mSystems 3.\u00a0https:\/\/doi.org\/10.1128\/mSystems.00020-18","DOI":"10.1128\/mSystems.00020-18"},{"key":"2781_CR23","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1161\/hypertensionaha.115.05315","volume":"65","author":"T Yang","year":"2015","unstructured":"Yang T et al (2015) Gut dysbiosis is linked to hypertension. Hypertension (Dallas, Tex.\u202f: 1979) 65:1331\u20131340. https:\/\/doi.org\/10.1161\/hypertensionaha.115.05315","journal-title":"Hypertension (Dallas, Tex. : 1979)"},{"key":"2781_CR24","doi-asserted-by":"publisher","first-page":"204589402092914","DOI":"10.1177\/2045894020929147","volume":"10","author":"TJ Sanada","year":"2020","unstructured":"Sanada TJ et al (2020) Gut microbiota modification suppresses the development of pulmonary arterial hypertension in an SU5416\/hypoxia rat model. Pulm Circ 10:2045894020929147. https:\/\/doi.org\/10.1177\/2045894020929147","journal-title":"Pulm Circ"},{"key":"2781_CR25","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40168-016-0222-x","volume":"5","author":"J Li","year":"2017","unstructured":"Li J et al (2017) Gut microbiota dysbiosis contributes to the development of hypertension. Microbiome 5:14. https:\/\/doi.org\/10.1186\/s40168-016-0222-x","journal-title":"Microbiome"},{"key":"2781_CR26","doi-asserted-by":"publisher","unstructured":"Zuo K et al (2019) Disordered gut microbiota and alterations in metabolic patterns are associated with atrial fibrillation. GigaScience 8.\u00a0https:\/\/doi.org\/10.1093\/gigascience\/giz058","DOI":"10.1093\/gigascience\/giz058"},{"key":"2781_CR27","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/nrcardio.2016.183","volume":"14","author":"AL Jonsson","year":"2017","unstructured":"Jonsson AL, B\u00e4ckhed F (2017) Role of gut microbiota in atherosclerosis. Nat Rev Cardiol 14:79\u201387. https:\/\/doi.org\/10.1038\/nrcardio.2016.183","journal-title":"Nat Rev Cardiol"},{"key":"2781_CR28","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.1161\/circulationaha.105.556746","volume":"112","author":"S Ryan","year":"2005","unstructured":"Ryan S, Taylor CT, McNicholas WT (2005) Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation 112:2660\u20132667. https:\/\/doi.org\/10.1161\/circulationaha.105.556746","journal-title":"Circulation"},{"key":"2781_CR29","doi-asserted-by":"publisher","unstructured":"Murphy AM, Thomas A, Crinion SJ, Kent BD, Tambuwala MM (2017) Intermittent hypoxia in obstructive sleep apnoea mediates insulin resistance through adipose tissue inflammation. Eur Respir J 49.\u00a0https:\/\/doi.org\/10.1183\/13993003.01731-2016","DOI":"10.1183\/13993003.01731-2016"},{"key":"2781_CR30","doi-asserted-by":"publisher","first-page":"637","DOI":"10.3390\/nu3060637","volume":"3","author":"A Hakansson","year":"2011","unstructured":"Hakansson A, Molin G (2011) Gut microbiota and inflammation. Nutrients 3:637\u2013682. https:\/\/doi.org\/10.3390\/nu3060637","journal-title":"Nutrients"},{"key":"2781_CR31","doi-asserted-by":"publisher","unstructured":"Cui L, Zhao T, Hu H, Zhang W, Hua X (2017) Association study of gut flora in coronary heart disease through high-throughput sequencing. Biomed Res Int\u00a02017:3796359. https:\/\/doi.org\/10.1155\/2017\/3796359","DOI":"10.1155\/2017\/3796359"},{"key":"2781_CR32","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1002\/ehf2.12596","volume":"7","author":"CC Mayerhofer","year":"2020","unstructured":"Mayerhofer CC et al (2020) Low fibre intake is associated with gut microbiota alterations in chronic heart failure. ESC Heart Fail 7:456\u2013466","journal-title":"ESC Heart Fail"},{"key":"2781_CR33","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.jff.2015.11.009","volume":"20","author":"P-H Liao","year":"2016","unstructured":"Liao P-H et al (2016) Lactobacillus reuteri GMNL-263 reduces hyperlipidaemia and the heart failure process in high-calorie diet-fed induced heart dysfunction in rats. J Funct Foods 20:226\u2013235","journal-title":"J Funct Foods"},{"key":"2781_CR34","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/s00280-018-3691-8","volume":"82","author":"L Zhao","year":"2018","unstructured":"Zhao L, Xing C, Sun W, Hou G, Yang G (2018) Lactobacillus supplementation prevents cisplatin-induced cardiotoxicity possibly by inflammation inhibition. Cancer Chemother Pharmacol 82:999\u20131008. https:\/\/doi.org\/10.1007\/s00280-018-3691-8","journal-title":"Cancer Chemother Pharmacol"},{"key":"2781_CR35","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1042\/cs20130339","volume":"127","author":"M Toral","year":"2014","unstructured":"Toral M et al (2014) The probiotic Lactobacillus coryniformis CECT5711 reduces the vascular pro-oxidant and pro-inflammatory status in obese mice. Clin Sci (London England\u202f: 1979) 127:33\u201345. https:\/\/doi.org\/10.1042\/cs20130339","journal-title":"Clin Sci (London England : 1979)"},{"key":"2781_CR36","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1161\/circresaha.118.313565","volume":"123","author":"M Malik","year":"2018","unstructured":"Malik M et al (2018) Lactobacillus plantarum 299v supplementation improves vascular endothelial function and reduces inflammatory biomarkers in men with stable coronary artery disease. Circ Res 123:1091\u20131102. https:\/\/doi.org\/10.1161\/circresaha.118.313565","journal-title":"Circ Res"},{"key":"2781_CR37","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvaa200","author":"MC Chaumais","year":"2020","unstructured":"Chaumais MC et al (2020) Additive protective effects of sacubitril\/valsartan and bosentan on vascular remodeling in experimental pulmonary hypertension. Cardiovasc Res. https:\/\/doi.org\/10.1093\/cvr\/cvaa200","journal-title":"Cardiovasc Res"}],"container-title":["Sleep and Breathing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11325-023-02781-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11325-023-02781-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11325-023-02781-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T11:29:38Z","timestamp":1695900578000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11325-023-02781-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,31]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["2781"],"URL":"https:\/\/doi.org\/10.1007\/s11325-023-02781-9","relation":{},"ISSN":["1520-9512","1522-1709"],"issn-type":[{"value":"1520-9512","type":"print"},{"value":"1522-1709","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,31]]},"assertion":[{"value":"21 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All applicable international, national, and\/or institutional guidelines for the care and use of animals were followed. All procedures performed in studies involving animals were in accordance with the ethical standards of Wannan Medical College. This article does not contain any studies with human participants performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}